{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:22:51Z","timestamp":1775791371862,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1038\/5517","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"157-163","source":"Crossref","is-referenced-by-count":2030,"title":["Tumoricidal activity of tumor necrosis factor\u2013related apoptosis\u2013inducing ligand in vivo"],"prefix":"10.1038","volume":"5","author":[{"given":"Henning","family":"Walczak","sequence":"first","affiliation":[]},{"given":"Robert E.","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Kiley","family":"Ariail","sequence":"additional","affiliation":[]},{"given":"Brian","family":"Gliniak","sequence":"additional","affiliation":[]},{"given":"Thomas S.","family":"Griffith","sequence":"additional","affiliation":[]},{"given":"Marek","family":"Kubin","sequence":"additional","affiliation":[]},{"given":"Wilson","family":"Chin","sequence":"additional","affiliation":[]},{"given":"Jon","family":"Jones","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Woodward","sequence":"additional","affiliation":[]},{"given":"Tiep","family":"Le","sequence":"additional","affiliation":[]},{"given":"Craig","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Pam","family":"Smolak","sequence":"additional","affiliation":[]},{"given":"Raymond G.","family":"Goodwin","sequence":"additional","affiliation":[]},{"given":"Charles T.","family":"Rauch","sequence":"additional","affiliation":[]},{"given":"JoAnn C.L.","family":"Schuh","sequence":"additional","affiliation":[]},{"given":"David H.","family":"Lynch","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0299_157_CR1","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","volume":"76","author":"CA Smith","year":"1994","unstructured":"Smith, C.A., Farrah, T. & Goodwin, R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959\u2013962 (1994).","journal-title":"Cell"},{"key":"BFnm0299_157_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/stem.5530120501","volume":"12","author":"D Cosman","year":"1994","unstructured":"Cosman, D. A family of ligands for the TNF receptor superfamily. Stem Cells 12, 440\u2013455 (1994).","journal-title":"Stem Cells"},{"key":"BFnm0299_157_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0952-7915(94)90119-8","volume":"6","author":"RJ Armitage","year":"1994","unstructured":"Armitage, R.J. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6, 407\u2013413 (1994).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm0299_157_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/oxfordjournals.bmb.a011633","volume":"53","author":"ME Peter","year":"1997","unstructured":"Peter, M.E., Ehret, A., Berndt, C. & Krammer, P.H. AIDS and the death receptors. Br. Med. Bull. 53, 604\u2013 616 (1997).","journal-title":"Br. Med. Bull."},{"key":"BFnm0299_157_CR5","first-page":"193","volume":"3","author":"J Cohen","year":"1988","unstructured":"Cohen, J. Cytokines as mediators of graft\u2013versus\u2013host disease. Bone Marrow Transplant. 3, 193\u2013197 (1988).","journal-title":"Bone Marrow Transplant."},{"key":"BFnm0299_157_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935\u2013946 (1995).","journal-title":"Cell"},{"key":"BFnm0299_157_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley, S.R. et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673\u2013682 (1995).","journal-title":"Immunity"},{"key":"BFnm0299_157_CR8","doi-asserted-by":"crossref","unstructured":"Griffith, T.S., Chin, W.A., Jackson, G.C., Lynch, D.H. & Kubin, M.Z. Intracellular regulation of TRAIL\u2013induced apoptosis in human melanoma cells. J. Immunol. 161, 2833\u20132840.","DOI":"10.4049\/jimmunol.161.6.2833"},{"key":"BFnm0299_157_CR9","doi-asserted-by":"publisher","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","volume":"271","author":"RM Pitti","year":"1996","unstructured":"Pitti, R.M. et al. Induction of apoptosis by Apo\u20132 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687\u201312690 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnm0299_157_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1083\/jcb.137.1.221","volume":"137","author":"SM Mariani","year":"1997","unstructured":"Mariani, S.M., Matiba, B., Armandola, E.A. & Krammer, P.H. Interleukin 1 \u03b2\u2013converting enzyme related proteases\/caspases are involved in TRAIL\u2013induced apoptosis of myeloma and leukemia cells. J. Cell. Biol. 137, 221\u2013229 (1997).","journal-title":"J. Cell. Biol."},{"key":"BFnm0299_157_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.277.5327.815","volume":"277","author":"G Pan","year":"1997","unstructured":"Pan, G. et al. An antagonist decoy receptor and a death domain\u2013containing receptor for TRAIL. Science 277, 815\u2013 818 (1997).","journal-title":"Science"},{"key":"BFnm0299_157_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.276.5309.111","volume":"276","author":"G Pan","year":"1997","unstructured":"Pan, G. et al. The receptor for the cytotoxic ligand TRAIL. Science 276, 111\u2013113 (1997).","journal-title":"Science"},{"key":"BFnm0299_157_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.277.5327.818","volume":"277","author":"JP Sheridan","year":"1997","unstructured":"Sheridan, J.P. et al. Control of TRAIL\u2013induced apoptosis by a family of signaling and decoy receptors. Science 277, 818\u2013 821 (1997).","journal-title":"Science"},{"key":"BFnm0299_157_CR14","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","volume":"16","author":"H Walczak","year":"1997","unstructured":"Walczak, H. et al. TRAIL\u2013R2: a novel apoptosis\u2013mediating receptor for TRAIL. EMBO J. 16, 5386\u2013 5397 (1997).","journal-title":"EMBO J."},{"key":"BFnm0299_157_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1084\/jem.186.7.1165","volume":"186","author":"MA Degli\u2013Esposti","year":"1997","unstructured":"Degli\u2013Esposti, M.A. et al. Cloning and characterization of TRAIL\u2013R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186, 1165\u20131170 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnm0299_157_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1074-7613(00)80399-4","volume":"7","author":"MA Degli\u2013Esposti","year":"1997","unstructured":"Degli\u2013Esposti, M.A. et al. The novel receptor TRAIL\u2013R4 induces NF\u2013\u03baB and protects against TRAIL\u2013mediated apoptosis, yet retains an incomplete death domain. Immunity 7, 813\u2013 820 (1997).","journal-title":"Immunity"},{"key":"BFnm0299_157_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0960-9822(06)00422-2","volume":"7","author":"SA Marsters","year":"1997","unstructured":"Marsters, S.A. et al. A novel receptor for Apo2L\/TRAIL contains a truncated death domain. Curr. Biol. 7, 1003\u2013 1006 (1997).","journal-title":"Curr. Biol."},{"key":"BFnm0299_157_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1006\/smim.1994.1035","volume":"6","author":"WC Fanslow","year":"1994","unstructured":"Fanslow, W.C. et al. Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6, 267\u2013 278 (1994).","journal-title":"Semin. Immunol."},{"key":"BFnm0299_157_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","volume":"187","author":"P Schneider","year":"1998","unstructured":"Schneider, P. et al. Conversion of membrane\u2013bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205\u20131213 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm0299_157_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/364806a0","volume":"364","author":"J Ogasawara","year":"1993","unstructured":"Ogasawara, J. et al. Lethal effect of the anti\u2013Fas antibody in mice. Nature 364, 806\u2013809 (1993).","journal-title":"Nature"},{"key":"BFnm0299_157_CR21","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.4049\/jimmunol.158.5.2303","volume":"158","author":"M Tanaka","year":"1997","unstructured":"Tanaka, M., Suda, T., Yatomi, T., Nakamura, N. & Nagata, S. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J. Immunol. 158, 2303\u20132309 (1997).","journal-title":"J. Immunol."},{"key":"BFnm0299_157_CR22","first-page":"223","volume":"129","author":"M Revel","year":"1987","unstructured":"Revel, M. & Schattner, A. Interferons: cytokines in autoimmunity. Ciba. Found. Symp. 129, 223\u2013 233 (1987).","journal-title":"Ciba. Found. Symp."},{"key":"BFnm0299_157_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0167-5699(88)91353-9","volume":"9","author":"A Cerami","year":"1988","unstructured":"Cerami, A. & Beutler, B. The role of cachectin\/TNF in endotoxic shock and cachexia. Immunol. Today 9, 28\u201331 (1988).","journal-title":"Immunol. Today"},{"key":"BFnm0299_157_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0014-5793(91)80803-B","volume":"285","author":"W Fiers","year":"1991","unstructured":"Fiers, W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285, 199\u2013 212 (1991).","journal-title":"FEBS Lett."},{"key":"BFnm0299_157_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","volume":"344","author":"MJ Elliott","year":"1994","unstructured":"Elliott, M.J. et al. Randomised double\u2013blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105\u2013 1110 (1994).","journal-title":"Lancet"},{"key":"BFnm0299_157_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM199707173370301","volume":"337","author":"LW Moreland","year":"1997","unstructured":"Moreland, L.W. et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)\u2013Fc fusion protein. N. Engl. J. Med. 337, 141\u2013147 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0299_157_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/377348a0","volume":"377","author":"LX Zheng","year":"1995","unstructured":"Zheng, L.X. et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348\u2013 351 (1995).","journal-title":"Nature"},{"key":"BFnm0299_157_CR28","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.154.6.2904","volume":"154","author":"P Vandenabeele","year":"1995","unstructured":"Vandenabeele, P., Declercq, W., Vanhaesebroeck, B., Grooten, J. & Fiers, W. Both TNF receptors are required for TNF\u2013mediated induction of apoptosis in PC60 cells. J. Immunol. 154, 2904\u20132913 (1995).","journal-title":"J. Immunol."},{"key":"BFnm0299_157_CR29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ijc.2910380521","volume":"38","author":"PG Brouckaert","year":"1986","unstructured":"Brouckaert, P.G., Leroux\u2013Roels, G.G., Guisez, Y., Tavernier, J. & Fiers, W. In vivo anti\u2013tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN\u2013\u03b3, on a syngeneic murine melanoma. Int. J. Cancer 38, 763\u2013769 (1986).","journal-title":"Int. J. Cancer"},{"key":"BFnm0299_157_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.167.3.1067","volume":"167","author":"EA Havell","year":"1988","unstructured":"Havell, E.A., Fiers, W. & North, R.J. The antitumor function of tumor necrosis factor d(TNF). I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J. Exp. Med. 167, 1067\u20131085 (1988).","journal-title":"J. Exp. Med."},{"key":"BFnm0299_157_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.181.1.71","volume":"181","author":"MR Alderson","year":"1995","unstructured":"Alderson, M.R. et al. Fas ligand mediates activation\u2013induced cell death in human T lymphocytes. J. Exp. Med. 181, 71\u201377 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0299_157_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/373438a0","volume":"373","author":"J Dhein","year":"1995","unstructured":"Dhein, J., Walczak, H., B\u00e4umler, C., Debatin, K.\u2013M. & Krammer, P.H. Autocrine T\u2013cell suicide mediated by APO\u20131\/(Fas\/CD95). Nature 373, 438\u2013441 (1995).","journal-title":"Nature"},{"key":"BFnm0299_157_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/373441a0","volume":"373","author":"T Brunner","year":"1995","unstructured":"Brunner, T. et al. Cell\u2013autonomous Fas (CD95)\/Fas\u2013ligand interaction mediates activation\u2013induced apoptosis in T\u2013cell hybridomas. Nature 373, 441\u2013444 (1995).","journal-title":"Nature"},{"key":"BFnm0299_157_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/373444a0","volume":"373","author":"S\u2013T Ju","year":"1995","unstructured":"Ju, S.\u2013T. et al. Fas(CD95)\/FasL interactions required for programmed cell death after T\u2013cell activation. Nature 373, 444\u2013448 (1995).","journal-title":"Nature"},{"key":"BFnm0299_157_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/370650a0","volume":"370","author":"B Lowin","year":"1994","unstructured":"Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. Cytolytic T\u2013cell\u2013cytotoxicity is mediated through perforin and Fas ligand pathways. Nature 370, 650\u2013653 (1994).","journal-title":"Nature"},{"key":"BFnm0299_157_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/369031a0","volume":"369","author":"D K\u00e4gi","year":"1994","unstructured":"K\u00e4gi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin\u2013deficient mice. Nature 369, 31\u201337 (1994).","journal-title":"Nature"},{"key":"BFnm0299_157_CR37","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.182.5.1223","volume":"182","author":"PR Galle","year":"1995","unstructured":"Galle, P.R. et al. Involvement of the CD95 (APO\u20131\/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223\u2013 1230 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0299_157_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nm0497-409","volume":"3","author":"T Kondo","year":"1997","unstructured":"Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential roles of the Fas ligand in the development of hepatitis. Nature Med. 3, 409\u2013 413 (1997).","journal-title":"Nature Med."},{"key":"BFnm0299_157_CR39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. & Ferguson, T.A. Fas ligand\u2013induced apoptosis as a mechanism of immune privilege. Science 270, 1189\u20131192 (1995).","journal-title":"Science"},{"key":"BFnm0299_157_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/377630a0","volume":"377","author":"D Bellgrau","year":"1995","unstructured":"Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature 377, 630\u2013632 (1995).","journal-title":"Nature"},{"key":"BFnm0299_157_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1083\/jcb.133.2.335","volume":"133","author":"LE French","year":"1996","unstructured":"French, L.E. et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune\u2013privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell. Biol. 133, 335\u2013343 (1996).","journal-title":"J. Cell. Biol."},{"key":"BFnm0299_157_CR42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","volume":"274","author":"M Hahne","year":"1996","unstructured":"Hahne, M. et al. Melanoma cell expression of Fas(Apo\u20131\/CD95) ligand: implications for tumor immune escape. Science 274, 1363\u20131366 (1996).","journal-title":"Science"},{"key":"BFnm0299_157_CR43","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nm1296-1361","volume":"2","author":"S Strand","year":"1996","unstructured":"Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO\u20131\/Fas) ligand\u2013expressing tumor cells\u2014a mechanism of immune evasion? Nature Med. 2, 1361\u20131366 (1996).","journal-title":"Nature Med."},{"key":"BFnm0299_157_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/smim.1996.0054","volume":"9","author":"B Matiba","year":"1997","unstructured":"Matiba, B., Mariani, S.M. & Krammer, P.H. The CD95 system and the death of a lymphocyte. Semin. Immunol. 9, 59\u201368 (1997).","journal-title":"Semin. Immunol."},{"key":"BFnm0299_157_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata, S. Apoptosis by death factor. Cell 88, 355\u2013 365 (1997).","journal-title":"Cell"},{"key":"BFnm0299_157_CR46","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","volume":"273","author":"JG Emery","year":"1998","unstructured":"Emery, J.G. et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273, 14363\u2013 14367 (1998).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0299_157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0299_157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0299_157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:02:36Z","timestamp":1684447356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0299_157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BFnm0299_157"],"URL":"https:\/\/doi.org\/10.1038\/5517","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}